Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
A wearable heart monitor worn for 14 days after an ER visit for unexplained fainting more than doubled the detection of serious arrhythmias compared to standard care, according to the ASPIRED trial. While it didn't reduce how often patients fainted again, it got them treated faster — and cut one-year mortality in half. Researchers say it could become routine ER practice.
Millions of people visit emergency departments each year with unexplained fainting (syncope), and about half leave without a clear diagnosis. The ASPIRED trial, presented at the European Society of Cardiology Congress and published in The New England Journal of Medicine, tested whether fitting patients with a 14-day wearable ECG patch right after their ED visit could change outcomes.
The trial enrolled 2,234 patients across 45 UK emergency departments. While early monitoring didn't significantly reduce the number of fainting episodes patients reported over the following year, it dramatically improved arrhythmia detection — and that appears to have saved lives.
By the Numbers:
Why it matters: Catching dangerous heart rhythms sooner means faster treatment — and potentially fewer deaths. Researchers argue that immediate post-ED ECG monitoring should become standard care for patients with unexplained syncope, though experts note the direct link between arrhythmia detection and mortality reduction still needs further study.
